Wound care has evolved significantly over the years, from simple bandages to biomaterial-based dressings that actively aid in healing and bleeding control. Traditional wound dressings primarily focus on covering the wound, but today’s advanced medical technologies accelerate the body’s natural healing process while reducing complications such as infections, excessive exudate, and delayed clot formation.

Among the most groundbreaking innovations in modern wound management are Axiostat and MaxioCel, two advanced solutions powered by chitosan technology.

• Axiostat: A life-saving haemostatic dressing designed to instantly stop bleeding in emergency, trauma, military, and vascular closure applications.
• MaxioCel: An advanced gelling fiber dressing that promotes faster healing and reduces pain in chronic wounds like diabetic foot ulcers, pressure ulcers, and post-operative wounds.

In this blog, we’ll explore their mechanisms of action, medical benefits, and diverse applications, highlighting how Axio Biosolutions is shaping the future of wound care and bleeding control.

Axiostat: Stopping Bleeding When Every Second Counts

What is Axiostat?

Axiostat is an advanced chitosan haemostatic dressing designed to rapidly control severe bleeding in trauma, emergency medicine, military applications, and surgical procedures. It utilizes Protonated Bioadhesive Technology (PBT®), which interacts with blood at the molecular level to form a strong, stable clot within minutes—even in patients on anticoagulant therapy.

Axiostat has been extensively used in military combat zones, hospitals, emergency response teams, and prehospital trauma care. It provides immediate and effective bleeding control, significantly improving patient outcomes in life-threatening hemorrhagic emergencies.

Key Properties of Axiostat

✔ Instant Bleeding Control – Binds to bleeding wounds via charge-based adhesion, rapidly forming a stable clot.
✔ Effective on Anticoagulated Patients – Unlike conventional gauze, Axiostat works effectively even in patients on blood thinners, reducing the risk of excessive bleeding.
✔Painless Removal – Can be easily removed by irrigating with saline or water, ensuring minimal trauma to the wound.
✔ Antimicrobial Protection – Chitosan’s natural antimicrobial action helps prevent wound infections.
✔ Rugged, Military-Grade Packaging – Vacuum-sealed and designed to withstand harsh battlefield environments.
✔ FDA 510(k) Cleared, CE Certified, NSN Codified – A trusted medical device for military, emergency responders, and hospitals worldwide.

Where is Axiostat Used?

Military & Battlefield Trauma – Used by armed forces worldwide for severe hemorrhage control in combat situations. Axiostat is designed to withstand extreme environments and provide rapid intervention in gunshot wounds, blast injuries, and shrapnel wounds.

1. Emergency & EMS Trauma – Essential for first responders and paramedics dealing with accidents, deep cuts, road traffic injuries, and violent trauma incidents.
2. Vascular Closure – Used in radial arterial access procedures like cardiac catheterization and angiography to achieve rapid hemostasis with minimal complications.

Axiostat in Battlefield Trauma

In a real-world combat casualty bleeding scenario, a soldier sustained a severe arterial wound during a field operation. Traditional gauze failed to control the massive blood loss, but Axiostat was applied, and bleeding stopped within 60 seconds. The soldier was stabilized and transported to surgical care, saving his life.

MaxioCel: A Breakthrough in Chronic Wound Care

What is MaxioCel?

Unlike traditional dressings that merely cover wounds, MaxioCel is an advanced gelling fiber dressing that actively absorbs exudates, promotes healing, and reduces infections. Made of chitosan-based biomaterials, it has been clinically proven to manage chronic wounds such as:

🔹 Diabetic Foot Ulcers (DFUs)
🔹 Pressure Ulcers (Bed Sores)
🔹 Venous Leg Ulcers
🔹 Post-Surgical Wounds
🔹 Burn Wounds

MaxioCel is particularly effective in chronic wound care where healing is delayed due to excessive inflammation, poor blood circulation, and bacterial infections.

Key Properties of MaxioCel

✔ Superior Exudate Management – Absorbs high levels of wound fluid, preventing maceration and promoting a moist healing environment.
✔ Painless Healing – Forms a soft gel matrix that doesn’t stick to the wound, allowing for pain-free dressing changes.
✔ Faster Healing – Supports angiogenesis and fibroblast activity, accelerating new tissue regeneration.
✔Antimicrobial Protection – Chitosan inhibits bacterial growth, reducing the risk of wound infections.
✔Hydrobalancing Effect – Maintains optimal moisture levels, ensuring the wound doesn’t dry out or become too wet.
✔Ideal for Chronic Wounds – Specifically designed for long-term wound management, improving quality of life for patients.

Where is MaxioCel Used?

Diabetic Foot Ulcers (DFUs) – MaxioCel significantly reduces wound size, promotes granulation tissue formation, and prevents amputations in diabetic patients.

Pressure Ulcers – Provides cushioning and moisture control for patients suffering from prolonged immobility.

Venous Leg Ulcers – Effectively manages wound exudates and speeds up healing, preventing chronic infections.

Burn Wounds – Protects the wound while allowing oxygen exchange, reducing scarring and infection risks.

Post-Surgical Wounds – Reduces the risk of surgical site infections (SSIs), leading to faster post-operative recovery.

MaxioCel in Diabetic Foot Ulcers

A 65-year-old diabetic patient with a non-healing foot ulcer was treated with MaxioCel for four weeks. The results:

✔ 75% reduction in wound size
✔ 31% increase in epithelial tissue growth
✔ 45% improvement in periwound skin condition

The patient avoided amputation, demonstrating the power of MaxioCel in chronic wound care.

Axiostat & MaxioCel: The Future of Wound Care

Both Axiostat and MaxioCel represent significant advancements in wound care and bleeding control. Whether it’s saving lives on the battlefield or promoting faster recovery in chronic wound patients, these solutions are redefining modern medical treatment.

🔹 Axiostat for trauma & emergency bleeding control
🔹 MaxioCel for long-term wound healing & chronic care

As Axio Biosolutions continues to lead biomaterial-based innovations, the future of wound care looks brighter than ever.

Conclusion: 

With Axiostat for emergency bleeding control and MaxioCel for chronic wound management, Axio Biosolutions continues to lead innovation in wound care. Whether it’s saving lives on the battlefield or healing chronic wounds faster, these biomaterial-based solutions are changing the future of wound management.

👉 Discover More at www.axiobio.com

Would you like to include clinical case studies or user testimonials to make this blog even stronger?